Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$30.8 - $52.47 $22,545 - $38,408
-732 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$28.4 - $50.7 $20,788 - $37,112
732 New
732 $25,000
Q4 2019

Feb 06, 2020

SELL
$36.31 - $46.83 $9,041 - $11,660
-249 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$35.66 - $44.99 $8,879 - $11,202
249 New
249 $9,000
Q2 2019

Aug 08, 2019

SELL
$36.57 - $47.97 $1.92 Million - $2.52 Million
-52,598 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$36.47 - $42.17 $202,226 - $233,832
-5,545 Reduced 9.54%
52,598 $2 Million
Q4 2018

Feb 07, 2019

SELL
$41.31 - $52.16 $9,997 - $12,622
-242 Reduced 0.41%
58,143 $2.5 Million
Q3 2018

Oct 30, 2018

BUY
$32.85 - $52.0 $1.92 Million - $3.04 Million
58,385 New
58,385 $2.87 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.